Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6622110rdf:typepubmed:Citationlld:pubmed
pubmed-article:6622110lifeskim:mentionsumls-concept:C0031676lld:lifeskim
pubmed-article:6622110lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:6622110lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6622110lifeskim:mentionsumls-concept:C0220934lld:lifeskim
pubmed-article:6622110lifeskim:mentionsumls-concept:C0205148lld:lifeskim
pubmed-article:6622110lifeskim:mentionsumls-concept:C0336862lld:lifeskim
pubmed-article:6622110pubmed:issue9lld:pubmed
pubmed-article:6622110pubmed:dateCreated1983-11-23lld:pubmed
pubmed-article:6622110pubmed:abstractTextSurface active aerosols were produced from aqueous dispersions of mixed lipids (CLL), extracted from bovine lung lavage. Particle size distributions were measured as a function of humidity for two types of aerosol generators: ultrasonic and jet. Lipid dispersions before aerosolization were prepared by sonication in an ice bath and by mechanical vortexing. Over a range of high humidity greater than 60-70%, ultrasonic nebulization gave CLL aerosols with mass median aerodynamic diameters (MMAD) of 1.4 +/- 0.1 micron, compatible with predicted alveolar deposition fractions of 0.2-0.3 according to current deposition models. For humidities of 30-95%, jet nebulization gave MMAD values of 0.4-0.5 micron, which have lower predicted alveolar deposition. The surface pressure-time (pi - t) adsorption characteristics at 35 +/- 2 degrees C of CLL dispersions prepared initially by vortexing or sonication were not significantly affected by ultrasonic nebulization over a 1-2 h time period. In addition, the dynamic surface tension lowering of both kinds of CLL dispersion was not affected by ultrasonic nebulization (minimum surface tension less than 1 dyne/cm at 37 degrees C and 100% humidity). Current interest in the treatment of the respiratory distress syndrome (RDS) with exogenous surfactant replacement has focused largely on the delivery of surfactant replacement has focused largely on h delivery of surfactants to infants by tracheal instillation at birth. However, the ability to form multi-component surfactant aerosols with appreciable alveolar deposition fractions and high surface activity may help to expand the utility of replacement therapy to patients with aerated lungs.lld:pubmed
pubmed-article:6622110pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6622110pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6622110pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6622110pubmed:languageenglld:pubmed
pubmed-article:6622110pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6622110pubmed:citationSubsetIMlld:pubmed
pubmed-article:6622110pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6622110pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6622110pubmed:statusMEDLINElld:pubmed
pubmed-article:6622110pubmed:monthSeplld:pubmed
pubmed-article:6622110pubmed:issn0031-3998lld:pubmed
pubmed-article:6622110pubmed:authorpubmed-author:McBrideJ TJTlld:pubmed
pubmed-article:6622110pubmed:authorpubmed-author:NotterR HRHlld:pubmed
pubmed-article:6622110pubmed:authorpubmed-author:MarksL BLBlld:pubmed
pubmed-article:6622110pubmed:authorpubmed-author:OberdorsterGGlld:pubmed
pubmed-article:6622110pubmed:issnTypePrintlld:pubmed
pubmed-article:6622110pubmed:volume17lld:pubmed
pubmed-article:6622110pubmed:ownerNLMlld:pubmed
pubmed-article:6622110pubmed:authorsCompleteYlld:pubmed
pubmed-article:6622110pubmed:pagination742-7lld:pubmed
pubmed-article:6622110pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:meshHeadingpubmed-meshheading:6622110-...lld:pubmed
pubmed-article:6622110pubmed:year1983lld:pubmed
pubmed-article:6622110pubmed:articleTitleUltrasonic and jet aerosolization of phospholipids and the effects on surface activity.lld:pubmed
pubmed-article:6622110pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6622110pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6622110pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6622110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6622110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6622110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6622110lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6622110lld:pubmed